The object of the present invention is a combination comprising a salt billion - theta epsilon_alpha_lambda_coalition type and coalition (VI) or a front and a alpha p_epsilon__or part A derivative. A pharmaceutical composition for which the invention is also directed comprises at least one salt theta_a_a lambda_billion, an alliance (VI) or a former alliance. And the alpha - (-) - (-) - (-) - or - ethers.The invention also has such a combination as an object, a drug on Friday for treatment and/or PI p_lambda_ The weight of malaria. The last packaging object of the present invention is used for the treatment and / or prevention of severe malaria.
展开▼